LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)
$0.172 0.0019 (1.117%)
Analysed LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) News Sources
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers
27-08-2025
yahoo.com
Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
18-09-2025
yahoo.com
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
15-10-2025
yahoo.com
What is the current price of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)?
The current price of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) is $0.172.
LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) since the previous trading day is $0.0019.
LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) since the previous trading day is 1.117%.
What is the most recent average sentiment score for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)?
The most recent average sentiment score for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)?
The most recent sentiment for LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ) is .
SEC-8K** Filing Available For LAUNCH ONE ACQUISITION - 29 (LPAAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.